Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma

Mansoor N. Saleh, M. B. Khazaeli, Richard H. Wheeler, Laquetta Allen, Arabella B. Tilden, William Grizzle, Ralph A. Reisfeld, Alice L. Yu, Stephen D. Gillies, Albert F. LoBuglio

Research output: Contribution to journalArticlepeer-review

122 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma'. Together they form a unique fingerprint.

Immunology and Microbiology